blood testing
The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.
The financing completes firm’s $60.1M Series B round.
CEO David Stein on how Babson Diagnostics is taking up Theranos' mission, but not its mantle.
The firm plans to further develop its blood typing technology.
The Cedars Sinai-incubated company plans to launch its first product in Q2 2019.
Pixel by LabCorp's mail-away screens offer insights on heart health, diabetes, colorectal cancer and general wellness.
Housed on a biochip, the startup's technology can deliver results from a single drop of blood within 15 minutes.